_id

691054beccc777a4e85d558d

Ticker

CRIS

Name

Curis Inc

Exchange

NASDAQ

Address

Building C, Lexington, MA, United States, 02421

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.curis.com

Description

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma; CA-170, an oral, small-molecule antagonist designated as CA-170 that selectively targets PD-L1 and VISTA; and CA-327, an oral, small molecule, TIM3/PD-L1, which is a molecule antagonist of PD-L1 and TIM3. It has collaboration agreements with Genentech Inc., or Genentech and F. Hoffmann-La Roche Ltd, or Roche, for the commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway antagonist for the treatment of advanced basal cell carcinoma, or BCC; Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology; and also licensed three programs under the Aurigene collaboration, including emavusertib. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts.

Last Close

1.29

Volume

117396

Current Price

1.25

Change

-3.1007751937984525

Last Updated

2025-11-29T11:51:03.213Z

Image

data:image/webp;base64,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

Ipo Date

2000-08-01T00:00:00.000Z

Market Cap

17712528

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.994

Sentiment Sources

1

Rating

4.6

Target Price

14

Strong Buy

3

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

3176000

Cost Of Revenue

15000

Gross Profit

3161000

Operating Expenses

10085000

Operating Income

-6924000

Interest Expense

-

Pretax Income

-7729000

Net Income

-7729000

Eps

-0.49291532277248384

Dividends Per Share

-

Shares Outstanding

12928853

Income Tax Expense

-

EBITDA

-7687000

Operating Margin

-218.01007556675063

Total Other Income Expense Net

-805000

Cash

9051000

Short Term Investments

-

Receivables

3243000

Inventories

-

Total Current Assets

13907000

Property Plant Equipment

2319000

Total Assets

27641000

Payables

4445000

Short Term Debt

8179000

Long Term Debt

-

Total Liabilities

42332000

Equity

-14691000

Depreciation

32000

Change In Working Capital

841000

Cash From Operations

-5569000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

4482000

Net Change In Cash

-1087000

PE

-

PB

-1.3341653052889524

ROE

52.610441767068274

ROA

-27.96208530805687

FCF

-5569000

Fcf Percent

-1.753463476070529

Piotroski FScore

1

Health Score

31

Deep Value Investing Score

2

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.8

Garp Investing Score

3.5

Growth Investing Score

3.5

Momentum Investing Score

3.5

Net Net Investing Score

1.5

Quality Investing Score

2.5

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

3176000

Quarters > 0 > income Statement > cost Of Revenue

15000

Quarters > 0 > income Statement > gross Profit

3161000

Quarters > 0 > income Statement > operating Expenses

10085000

Quarters > 0 > income Statement > operating Income

-6924000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-7729000

Quarters > 0 > income Statement > net Income

-7729000

Quarters > 0 > income Statement > eps

-0.49291532277248384

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

15680178

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-7687000

Quarters > 0 > income Statement > operating Margin

-218.01007556675063

Quarters > 0 > income Statement > total Other Income Expense Net

-805000

Quarters > 0 > balance Sheet > cash

9051000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

3243000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

13907000

Quarters > 0 > balance Sheet > property Plant Equipment

2319000

Quarters > 0 > balance Sheet > total Assets

27641000

Quarters > 0 > balance Sheet > payables

4445000

Quarters > 0 > balance Sheet > short Term Debt

8179000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

42332000

Quarters > 0 > balance Sheet > equity

-14691000

Quarters > 0 > cash Flow > net Income

-7729000

Quarters > 0 > cash Flow > depreciation

32000

Quarters > 0 > cash Flow > change In Working Capital

841000

Quarters > 0 > cash Flow > cash From Operations

-5569000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

4482000

Quarters > 0 > cash Flow > net Change In Cash

-1087000

Quarters > 0 > ratios > PE

-0.49291532277248384

Quarters > 0 > ratios > PB

-1.3341653052889524

Quarters > 0 > ratios > ROE

52.610441767068274

Quarters > 0 > ratios > ROA

-27.96208530805687

Quarters > 0 > ratios > FCF

-5569000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-1.753463476070529

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

2749000

Quarters > 1 > income Statement > cost Of Revenue

16000

Quarters > 1 > income Statement > gross Profit

2733000

Quarters > 1 > income Statement > operating Expenses

10984000

Quarters > 1 > income Statement > operating Income

-8251000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-8593000

Quarters > 1 > income Statement > net Income

-8593000

Quarters > 1 > income Statement > eps

-0.680491366557805

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

12627640

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-8209000

Quarters > 1 > income Statement > operating Margin

-300.14550745725717

Quarters > 1 > income Statement > total Other Income Expense Net

-342000

Quarters > 1 > balance Sheet > cash

10138000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

2752000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

14419000

Quarters > 1 > balance Sheet > property Plant Equipment

2673000

Quarters > 1 > balance Sheet > total Assets

29234000

Quarters > 1 > balance Sheet > payables

4097000

Quarters > 1 > balance Sheet > short Term Debt

1265000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

43220000

Quarters > 1 > balance Sheet > equity

-13986000

Quarters > 1 > cash Flow > net Income

-8593000

Quarters > 1 > cash Flow > depreciation

42000

Quarters > 1 > cash Flow > change In Working Capital

-909000

Quarters > 1 > cash Flow > cash From Operations

-8009000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

-2135000

Quarters > 1 > cash Flow > net Change In Cash

-10144000

Quarters > 1 > ratios > PE

-0.680491366557805

Quarters > 1 > ratios > PB

-1.1285964535964537

Quarters > 1 > ratios > ROE

61.440011440011446

Quarters > 1 > ratios > ROA

-29.39385646849559

Quarters > 1 > ratios > FCF

-8009000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-2.913423062931975

Quarters > 1 > health Score

31

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

2380000

Quarters > 2 > income Statement > cost Of Revenue

14000

Quarters > 2 > income Statement > gross Profit

2366000

Quarters > 2 > income Statement > operating Expenses

12523000

Quarters > 2 > income Statement > operating Income

-10157000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-10616000

Quarters > 2 > income Statement > net Income

-10616000

Quarters > 2 > income Statement > eps

-1.2498401791594567

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

8493886

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-10098000

Quarters > 2 > income Statement > operating Margin

-426.7647058823529

Quarters > 2 > income Statement > total Other Income Expense Net

-459000

Quarters > 2 > balance Sheet > cash

20282000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

2315000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

24811000

Quarters > 2 > balance Sheet > property Plant Equipment

3029000

Quarters > 2 > balance Sheet > total Assets

39326000

Quarters > 2 > balance Sheet > payables

5104000

Quarters > 2 > balance Sheet > short Term Debt

1301000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

45933000

Quarters > 2 > balance Sheet > equity

-6607000

Quarters > 2 > cash Flow > net Income

-10616000

Quarters > 2 > cash Flow > depreciation

59000

Quarters > 2 > cash Flow > change In Working Capital

1834000

Quarters > 2 > cash Flow > cash From Operations

-7252000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

7537000

Quarters > 2 > cash Flow > net Change In Cash

285000

Quarters > 2 > ratios > PE

-1.2498401791594567

Quarters > 2 > ratios > PB

-1.6069861510519146

Quarters > 2 > ratios > ROE

160.67806871499923

Quarters > 2 > ratios > ROA

-26.994863449117634

Quarters > 2 > ratios > FCF

-7252000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-3.0470588235294116

Quarters > 2 > health Score

31

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

3345000

Quarters > 3 > income Statement > cost Of Revenue

17000

Quarters > 3 > income Statement > gross Profit

3328000

Quarters > 3 > income Statement > operating Expenses

12322000

Quarters > 3 > income Statement > operating Income

-8994000

Quarters > 3 > income Statement > interest Expense

615000

Quarters > 3 > income Statement > pretax Income

-9618000

Quarters > 3 > income Statement > net Income

-9618000

Quarters > 3 > income Statement > eps

-1.2537761239207397

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

7671226

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-7210000

Quarters > 3 > income Statement > operating Margin

-268.8789237668162

Quarters > 3 > income Statement > total Other Income Expense Net

-624000

Quarters > 3 > balance Sheet > cash

19997000

Quarters > 3 > balance Sheet > short Term Investments

0

Quarters > 3 > balance Sheet > receivables

3349000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

26385000

Quarters > 3 > balance Sheet > property Plant Equipment

3394000

Quarters > 3 > balance Sheet > total Assets

41265000

Quarters > 3 > balance Sheet > payables

3024000

Quarters > 3 > balance Sheet > short Term Debt

1336000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

47263000

Quarters > 3 > balance Sheet > equity

-5998000

Quarters > 3 > cash Flow > net Income

-9618000

Quarters > 3 > cash Flow > depreciation

16000

Quarters > 3 > cash Flow > change In Working Capital

-2052000

Quarters > 3 > cash Flow > cash From Operations

-9260000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-428000

Quarters > 3 > cash Flow > cash From Financing

8831000

Quarters > 3 > cash Flow > net Change In Cash

-857000

Quarters > 3 > ratios > PE

-1.2537761239207397

Quarters > 3 > ratios > PB

-1.5987049849949984

Quarters > 3 > ratios > ROE

160.35345115038348

Quarters > 3 > ratios > ROA

-23.30788804071247

Quarters > 3 > ratios > FCF

-9260000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-2.7683109118086695

Quarters > 3 > health Score

31

Valuation > metrics > PE

-0.49291532277248384

Valuation > metrics > PB

-1.3341653052889524

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

52.610441767068274

Profitability > metrics > ROA

-55.57632846767815

Profitability > metrics > Net Margin

-2.433564231738035

Profitability > final Score

40

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-164.85714285714286

Risk > final Score

-629

Risk > verdict

High

Liquidity > metrics > Current Ratio

1.1016318124207858

Liquidity > metrics > Quick Ratio

1.1016318124207858

Liquidity > final Score

78

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

40

Prev Profitabilities > 1

40

Prev Profitabilities > 2

40

Prev Risks > 0

-56

Prev Risks > 1

-48

Prev Risks > 2

-28

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-13T00:33:34.150Z